Gene · 6495
Papers2,008
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,008
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37867435 | PubTator, text mining | PubMed |
| Developmental estrogen exposure in mice disrupts uterine epithelial cell differentiation and causes adenocarcinoma via Wnt/β-catenin and PI3K/AKT signaling. | PLoS Biol | 2023 | 37856394 | PubTator, text mining | PubMed |
| Zmym4 is required for early cranial gene expression and craniofacial cartilage formation. | Front Cell Dev Biol | 2023 | 37854072 | PubTator, text mining | PubMed |
| Parvimonas micra, an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes. | Gut Microbes | 2023 | 37842920 | PubTator, text mining | PubMed |
| PITX1 plays essential functions in cancer. | Front Oncol | 2023 | 37841446 | PubTator, text mining | PubMed |
| miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer. | Front Oncol | 2023 | 37841425 | PubTator, text mining | PubMed |
| Rewiring of the promoter-enhancer interactome and regulatory landscape in glioblastoma orchestrates gene expression underlying neurogliomal synaptic communication. | Nat Commun | 2023 | 37833281 | PubTator, text mining | PubMed |
| Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer. | Front Immunol | 2023 | 37828981 | PubTator, text mining | PubMed |
| A Novel EYA1 Mutation Causing Alternative RNA Splicing in a Chinese Family With Branchio-Oto Syndrome: Implications for Molecular Diagnosis and Clinical Application. | Clin Exp Otorhinolaryngol | 2023 | 37817567 | PubTator, text mining | PubMed |
| Altered binding affinity of SIX1-Q177R correlates with enhanced WNT5A and WNT pathway effector expression in Wilms tumor. | Dis Model Mech | 2023 | 37815464 | PubTator, text mining | PubMed |
| A child with branchio-oto-renal spectrum disorder carrying an SIX1 variant. | Pediatr Int | 2023 | 37795857 | PubTator, text mining | PubMed |
| Identification of SNP markers for canine mammary gland tumours in females based on a genome-wide association study - preliminary results. | J Vet Res | 2023 | 37786854 | PubTator, text mining | PubMed |
| A Positive Feedback Loop of E2F4-Mediated Activation of MNX1 Regulates Tumour Progression in Colorectal Cancer. | J Cancer | 2023 | 37779874 | PubTator, text mining | PubMed |
| UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology. | Oncotarget | 2023 | 37769033 | PubTator, text mining | PubMed |
| The Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells. | Int J Mol Sci | 2023 | 37762231 | PubTator, text mining | PubMed |
| An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer. | BMC Cancer | 2023 | 37723477 | PubTator, text mining | PubMed |
| Erratum: [Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1. | Oncol Lett | 2023 | 37720668 | PubTator, text mining | PubMed |
| A pancreatic adenocarcinoma mimicking hepatoid carcinoma of uncertain histogenesis: A case report and literature review. | Oncol Lett | 2023 | 37720666 | PubTator, text mining | PubMed |
| Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor. | Sci Rep | 2023 | 37717078 | PubTator, text mining | PubMed |
| A Review: Methodologies to Promote the Differentiation of Mesenchymal Stem Cells for the Regeneration of Intervertebral Disc Cells Following Intervertebral Disc Degeneration. | Cells | 2023 | 37681893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6495/papers?page=9